Other Stories

China's Sinovac inviting foreign press to promote safety of its vaccine candidate Updated: 2020-09-24 10:02:13 KST

Chinese firm Sinovac Biotech is set to unveil its COVID-19 vaccine candidate to foreign press as China's proposes to begin vaccinations as early as November.
The company says it wants to show them the development and production of the vaccine and openly promote its safety.
This comes amid rising suspicions as no side effects have been reported during clinical trials, while pharmaceutical firms in the U.S. and the U.K. have confirmed adverse effects.
Sinovac's vaccine candidate, called CoronaVac is being tested in Brazil and Indonesia.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.